The optimum route for cardioplegia administration in patients with severe coronary disease is still under debate. This study compared clinical, echocardiographic, and biochemical results in patients with left main stem disease treated with 2 different strategies of myocardial protection.
Does antegrade blood cardioplegia alone provide adequate myocardial protection in patients with left main stem disease?
Onorati, Francesco;
2003-01-01
Abstract
The optimum route for cardioplegia administration in patients with severe coronary disease is still under debate. This study compared clinical, echocardiographic, and biochemical results in patients with left main stem disease treated with 2 different strategies of myocardial protection.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
A+Rcardioplegia_in_LMSD_JTCVS2003.pdf
solo utenti autorizzati
Tipologia:
Versione dell'editore
Licenza:
Accesso ristretto
Dimensione
196.17 kB
Formato
Adobe PDF
|
196.17 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
